US5166057A
(en)
*
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
US20060019350A1
(en)
*
|
1989-08-28 |
2006-01-26 |
Peter Palese |
Recombinant negative strand RNA virus expression system and vacccines
|
US5840520A
(en)
*
|
1989-08-28 |
1998-11-24 |
Aviron |
Recombinant negative strand RNA virus expression systems
|
US5854037A
(en)
*
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
US6887699B1
(en)
*
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
WO1992003454A1
(en)
*
|
1990-08-14 |
1992-03-05 |
Isis Pharmaceuticals, Inc. |
Inhibition of influenza virus type a, ann arbor strain h2n2 by antisense oligonucleotides
|
US7374768B1
(en)
*
|
1990-09-25 |
2008-05-20 |
Xenova Research Limited |
Viral vaccines
|
US5665362A
(en)
*
|
1990-09-25 |
1997-09-09 |
Cantab Pharmaceuticals Research Limited |
Viral vaccines
|
US5837261A
(en)
*
|
1990-09-25 |
1998-11-17 |
Cantab Pharmaceuticals Research Limited |
Viral vaccines
|
EP0492920A1
(de)
*
|
1990-12-24 |
1992-07-01 |
Merck & Co. Inc. |
Chimärer Influenza-HIV Impfstoff
|
CA2084180A1
(en)
*
|
1991-12-11 |
1993-06-12 |
Paul P. Hung |
Expression of specific immunogens using viral antigens
|
ES2247584T3
(es)
*
|
1992-04-14 |
2006-03-01 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Virus atenuados por ingenieria genetica.
|
WO1994013837A1
(en)
*
|
1992-12-07 |
1994-06-23 |
Lionel Resnick |
Method for detecting a virus
|
EP0711340A4
(de)
*
|
1993-06-11 |
1998-02-04 |
Peter M Palese |
Hohe ausbeuten an influenzenvirus
|
US7344722B1
(en)
*
|
1993-06-29 |
2008-03-18 |
The Regents Of The University Of Michigan |
Cold-adapted influenza virus
|
AU2359195A
(en)
*
|
1994-04-19 |
1995-11-10 |
Thomas Jefferson University |
Viral ribonucleocapsid as an immunological enhancer
|
EP0760013B1
(de)
*
|
1994-05-20 |
2003-07-16 |
The Mount Sinai School Of Medicine, Of The City University Of New York |
Behandlung von influenzavirus-infektion unter verwendung von antiviralen acylierung/palmitylierung von hemagglutinin hemmen
|
DE69532369T3
(de)
|
1994-07-18 |
2010-11-04 |
Conzelmann, Karl-Klaus, Prof. Dr. |
Rekombinantes infektiöses nicht-in-Segmente-geteiltes, negativ-Strange-RNS-Virus
|
US20030054505A1
(en)
|
1997-09-26 |
2003-03-20 |
Hong Jin |
Recombinant rsv expression systems and vaccines
|
US5716821A
(en)
*
|
1994-09-30 |
1998-02-10 |
Uab Research Foundation |
Prevention and treatment of respiratory tract disease
|
US5597697A
(en)
*
|
1994-09-30 |
1997-01-28 |
Diamond; Paul |
Screening assay for inhibitors and activators of RNA and DNA-dependent nucleic acid polymerases
|
WO1996010400A1
(en)
*
|
1994-09-30 |
1996-04-11 |
The Uab Research Foundation |
Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses
|
US7465574B2
(en)
*
|
1994-09-30 |
2008-12-16 |
Medimmune, Llc |
Recombinant RSV virus expression systems and vaccines
|
EP0704533A1
(de)
*
|
1994-09-30 |
1996-04-03 |
Bayer Ag |
Abgeschwächtes Impfvirus, Verfahren zur dessen Herstellung und Arzneimittel die es enthalten
|
AU3760495A
(en)
*
|
1994-09-30 |
1996-04-26 |
Aviron |
Chimeric Influenza Virus And Electroporation Method
|
US6146873A
(en)
*
|
1994-11-10 |
2000-11-14 |
Baxter Aktiengesellschaft |
Production of orthomyxoviruses in monkey kidney cells using protein-free media
|
US5698433A
(en)
*
|
1994-11-10 |
1997-12-16 |
Immuno Ag |
Method for producing influenza virus and vaccine
|
US5753489A
(en)
*
|
1994-11-10 |
1998-05-19 |
Immuno Ag |
Method for producing viruses and vaccines in serum-free culture
|
US5756341A
(en)
*
|
1994-11-10 |
1998-05-26 |
Immuno Ag |
Method for controlling the infectivity of viruses
|
DE19503082A1
(de)
*
|
1995-02-01 |
1996-08-08 |
Univ Ludwigs Albert |
Gegenstand und Verfahren zur bevorzugt transienten Expression und möglichen Translation spezifischer RNA im cytoplasmatischen Bereich höherer eukaryontischer Zellen
|
US7153510B1
(en)
*
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
DE69510207T3
(de)
*
|
1995-08-09 |
2007-02-15 |
Schweiz. Serum- & Impfinstitut Bern |
Verfahren zur Herstellung von infektiösen minussträngigen RNA-Viren
|
DK0864645T3
(da)
|
1995-10-31 |
2005-10-24 |
Dnavec Research Inc |
Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet
|
KR100525687B1
(ko)
*
|
1995-11-01 |
2005-11-25 |
가부시끼가이샤 디나벡 겡뀨쇼 |
재조합체 센다이바이러스
|
ES2109189B1
(es)
*
|
1996-03-14 |
1998-05-16 |
Iberica Cyanamid |
Vectores basados en genomas virales defectivos recombinantes y su empleo en la formulacion de vacunas.
|
WO1997041245A1
(en)
*
|
1996-05-01 |
1997-11-06 |
The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services |
Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins
|
US6022863A
(en)
*
|
1996-05-21 |
2000-02-08 |
Yale University |
Regulation of gene expression
|
US5939262A
(en)
|
1996-07-03 |
1999-08-17 |
Ambion, Inc. |
Ribonuclease resistant RNA preparation and utilization
|
US5677124A
(en)
*
|
1996-07-03 |
1997-10-14 |
Ambion, Inc. |
Ribonuclease resistant viral RNA standards
|
EP1860192A1
(de)
|
1996-09-17 |
2007-11-28 |
Novartis Vaccines and Diagnostics, Inc. |
Zusammensetzungen und Verfahren zur Behandlung intrazellulärer Erkrankungen
|
US6544523B1
(en)
*
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
US20030125280A1
(en)
*
|
1996-12-03 |
2003-07-03 |
Medical University Of South Carolina |
Tissue specific and target RNA-specific ribozymes as antimicrobial therapeutics against microbial pathogens
|
US6884414B1
(en)
*
|
1997-04-30 |
2005-04-26 |
Mount Sinai School Of Medicine Of New York University |
Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
|
AU736586B2
(en)
|
1997-05-07 |
2001-08-02 |
Cleveland Clinic Foundation, The |
An infectious clone for human parainfluenza virus type 3
|
WO1999006576A1
(en)
|
1997-08-04 |
1999-02-11 |
Calydon, Inc. |
A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
|
US6872518B2
(en)
*
|
1997-09-22 |
2005-03-29 |
University Of Rochester |
Methods for selecting polynucleotides encoding T cell epitopes
|
US6830748B1
(en)
|
1997-09-26 |
2004-12-14 |
Medimmune Vaccines, Inc. |
Recombinant RSV virus expression systems and vaccines
|
AU9363798A
(en)
|
1997-11-06 |
1999-05-31 |
Chiron S.P.A. |
Neisserial antigens
|
CA2317815A1
(en)
|
1998-01-14 |
1999-07-22 |
Chiron S.P.A. |
Neisseria meningitidis antigens
|
DE69900592T2
(de)
*
|
1998-02-27 |
2002-08-22 |
Pamgene Bv |
Verfahren zur unspezifischen amplifizierung einer nukleinsäure
|
CA2325564A1
(en)
*
|
1998-03-27 |
1999-10-07 |
Cytos Biotechnology Ag |
Inducible alphaviral gene expression system
|
ES2304065T3
(es)
|
1998-05-01 |
2008-09-01 |
Novartis Vaccines And Diagnostics, Inc. |
Antigenos y composiciones de neisseria meningitidis.
|
DE69937999T2
(de)
*
|
1998-06-12 |
2009-01-29 |
Avir Green Hills Biotechnology Research Development Trade Ag |
Interferon induzierende genetisch veränderte attenuierte viren
|
AU771110B2
(en)
|
1998-06-12 |
2004-03-11 |
Mount Sinai School Of Medicine Of The City University Of New York, The |
Novel methods and interferon deficient substrates for the propagation of viruses
|
CA2331782A1
(en)
*
|
1998-06-24 |
1999-12-29 |
Musc Foundation For Research Development |
Tissue-specific and target rna-specific ribozymes
|
US6451579B1
(en)
|
1998-07-29 |
2002-09-17 |
Invitrogen Corporation |
Regulated expression of recombinant proteins using RNA viruses
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
US6544785B1
(en)
*
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
US6720415B2
(en)
*
|
1998-12-02 |
2004-04-13 |
Princeton University |
Compositions and methods for regulating bacterial pathogenesis
|
US7326542B2
(en)
*
|
1998-12-02 |
2008-02-05 |
Princeton University |
Compositions and methods for regulating bacterial pathogenesis
|
EP1035209A1
(de)
*
|
1999-03-06 |
2000-09-13 |
ARTEMIS Pharmaceuticals GmbH |
Stabile rekombinante Influenzaviren, die frei von Helfervirus sind
|
US6864235B1
(en)
|
1999-04-01 |
2005-03-08 |
Eva A. Turley |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US6911429B2
(en)
*
|
1999-04-01 |
2005-06-28 |
Transition Therapeutics Inc. |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US8715940B2
(en)
|
1999-04-06 |
2014-05-06 |
Wisconsin Alumni Research Foundation |
Method of making recombinant influenza virus
|
AU778737B2
(en)
*
|
1999-04-14 |
2004-12-16 |
Musc Foundation For Research Development |
Tissue-specific and pathogen-specific toxic agents and ribozymes
|
US6271359B1
(en)
|
1999-04-14 |
2001-08-07 |
Musc Foundation For Research Development |
Tissue-specific and pathogen-specific toxic agents and ribozymes
|
NZ581940A
(en)
|
1999-04-30 |
2011-07-29 |
Novartis Vaccines & Diagnostic |
Conserved neisserial antigens
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
CN1451038A
(zh)
*
|
1999-07-30 |
2003-10-22 |
埃西斯创新有限公司 |
可用作疫苗的减毒流感病毒
|
RU2281956C2
(ru)
|
1999-10-29 |
2006-08-20 |
Чирон С.Р.Л. |
Антигенные пептиды neisseria
|
AU1647501A
(en)
|
1999-12-10 |
2001-06-18 |
Cytos Biotechnology Ag |
Replicon based activation of endogenous genes
|
DK2289545T3
(en)
|
2000-01-17 |
2016-09-05 |
Glaxosmithkline Biologicals Sa |
Supplemented OMV vaccine against meningococcus
|
US6764685B1
(en)
*
|
2000-03-21 |
2004-07-20 |
Medimmune Vaccines, Inc. |
Recombinant parainfluenza virus expression systems and vaccines
|
US20030194696A1
(en)
*
|
2000-03-28 |
2003-10-16 |
University Of Rochester |
Methods of producing a library and methods of selecting polynucleotides of interest
|
EP1268763A2
(de)
*
|
2000-03-28 |
2003-01-02 |
University Of Rochester |
Verfahren zur herstellung einer bibliothek und zur selektion von polynukleotiden
|
AU2001257001A1
(en)
*
|
2000-04-10 |
2001-10-23 |
Mount Sinai School Of Medicine Of New York University |
Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
|
EP1702983A3
(de)
|
2000-04-13 |
2007-01-10 |
Medical University of South Carolina |
Gewebespezifische und pathogenspezifische giftige Verbindungen, Ribozyme, DNAzyme und Antisenseolinukleotide sowie Anwendungen dafür
|
WO2001083794A2
(en)
*
|
2000-04-28 |
2001-11-08 |
St. Jude Children's Research Hospital |
Dna transfection system for the generation of infectious influenza virus
|
AU2001256609A1
(en)
*
|
2000-05-12 |
2001-11-20 |
Cyril John Higgins |
Method of organized retrieval of world-wide web pages
|
EP1950297A2
(de)
|
2000-05-31 |
2008-07-30 |
Novartis Vaccines and Diagnostics, Inc. |
Zusammensetzungen und Verfahren zur Behandlung neoplastischer Erkrankungen mithilfe von Chemotherapie und Strahlungssensibilisatoren
|
WO2002000883A2
(en)
*
|
2000-06-23 |
2002-01-03 |
American Cyanamid Company |
Rescue of canine distemper virus from cdna
|
NZ523831A
(en)
*
|
2000-07-13 |
2005-10-28 |
Invitrogen Corp |
Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix
|
US20020165192A1
(en)
*
|
2000-09-19 |
2002-11-07 |
Kerr William G. |
Control of NK cell function and survival by modulation of ship activity
|
US7691821B2
(en)
|
2001-09-19 |
2010-04-06 |
University Of South Florida |
Inhibition of SHIP to enhance stem cell harvest and transplantation
|
EP2189473A3
(de)
|
2000-10-27 |
2010-08-11 |
Novartis Vaccines and Diagnostics S.r.l. |
Nukleinsäure und Proteine von Gruppen A und B Streptokokken
|
US20040209263A1
(en)
*
|
2000-12-07 |
2004-10-21 |
Clawson Gary A. |
Selection of catalytic nucleic acids targeted to infectious agents
|
WO2002098457A2
(en)
*
|
2001-01-17 |
2002-12-12 |
Thomas Jefferson University |
Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
|
US20030232061A1
(en)
*
|
2001-10-18 |
2003-12-18 |
Fouchier Ronaldus Adrianus Maria |
Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
|
CN101921732A
(zh)
|
2001-01-19 |
2010-12-22 |
维洛诺瓦蒂夫公司 |
在易感哺乳动物中引起呼吸道疾病的病毒
|
US8715922B2
(en)
*
|
2001-01-19 |
2014-05-06 |
ViroNovative |
Virus causing respiratory tract illness in susceptible mammals
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
AU2002309133A1
(en)
|
2001-04-17 |
2002-10-28 |
Institut Pasteur |
Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
|
GB0123276D0
(en)
|
2001-09-27 |
2001-11-21 |
Imp College Innovations Ltd |
Uses of agents that bind immune-system components
|
JP4413617B2
(ja)
|
2001-12-12 |
2010-02-10 |
カイロン ソチエタ ア レスポンサビリタ リミタータ |
Chlamydiatrachomatisに対する免疫化
|
US7820435B2
(en)
*
|
2002-02-06 |
2010-10-26 |
Expression Technologies Inc. |
De novo synthesized plasmid, methods of making and use thereof
|
US7226774B2
(en)
*
|
2002-02-13 |
2007-06-05 |
Wisconsin Alumni Research Foundation |
Signal for packaging of influenza virus vectors
|
KR101011410B1
(ko)
*
|
2002-02-13 |
2011-01-28 |
위스콘신 얼럼나이 리서어치 화운데이션 |
인플루엔자 바이러스 벡터의 패키징을 위한 신호
|
IL163646A0
(en)
|
2002-02-21 |
2005-12-18 |
Vironovative Bv |
Recombinant parainfluenza virus expression systemsand vaccines comprising heterologous antigens derived from metapneumovirus
|
EP1485488A4
(de)
*
|
2002-02-21 |
2005-03-02 |
Sinai School Medicine |
Rekombinante expressionssysteme für minusstrang-virus-rna und impfstoffe
|
US7465456B2
(en)
|
2002-04-26 |
2008-12-16 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
AU2003231083A1
(en)
|
2002-04-26 |
2003-11-10 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
US7563882B2
(en)
|
2002-06-10 |
2009-07-21 |
University Of Rochester |
Polynucleotides encoding antibodies that bind to the C35 polypeptide
|
JP2005533861A
(ja)
*
|
2002-07-25 |
2005-11-10 |
メデュームン,インコーポレーテッド |
抗RSV、抗hMPV、および抗PIV抗体を使用するRSV、hMPV、およびPIVの治療法と予防法
|
EP1572108A4
(de)
*
|
2002-09-27 |
2008-09-17 |
Medimmune Vaccines Inc |
Funktionale mutationen des rsv (respiratory syncytial virus)
|
US20070224124A1
(en)
*
|
2002-09-30 |
2007-09-27 |
University Of South Florida |
Novel SH2containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein
|
DK2279746T3
(da)
|
2002-11-15 |
2013-11-25 |
Novartis Vaccines & Diagnostic |
Overfladeproteiner i neisseria meningitidis
|
WO2004063351A2
(en)
|
2003-01-09 |
2004-07-29 |
Macrogenics, Inc. |
IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT Fc REGIONS AND METHODS OF USING SAME
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
US7704720B2
(en)
*
|
2003-04-25 |
2010-04-27 |
Medimmune, Llc |
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
|
KR20110097971A
(ko)
*
|
2003-04-25 |
2011-08-31 |
메디뮨 백신즈, 인코포레이티드 |
메타뉴모바이러스 유래 이종 항원을 포함하는 재조합 파라인플루엔자 바이러스 발현 시스템 및 백신
|
EP1631663B1
(de)
*
|
2003-05-28 |
2016-08-24 |
Wisconsin Alumni Research Foundation |
Rekombinante influenza viren mit hohem titer zur impfung und gentherapie
|
WO2005018539A2
(en)
*
|
2003-06-16 |
2005-03-03 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
WO2005019449A2
(en)
*
|
2003-07-03 |
2005-03-03 |
Board Of Trustees Operating Michigan State University |
Expression of a recombinant transgene
|
US20050054847A1
(en)
*
|
2003-08-01 |
2005-03-10 |
Invitrogen Corporation |
Compositions and methods for preparing short RNA molecules and other nucleic acids
|
US7807646B1
(en)
|
2003-11-20 |
2010-10-05 |
University Of South Florida |
SHIP-deficiency to increase megakaryocyte progenitor production
|
US7763592B1
(en)
|
2003-11-20 |
2010-07-27 |
University Of South Florida |
SHIP-deficiency to increase megakaryocyte progenitor production
|
DE602004027537D1
(de)
*
|
2003-12-23 |
2010-07-15 |
Medimmune Inc |
|
DE202005022108U1
(de)
|
2004-03-09 |
2013-11-12 |
Novartis Vaccines And Diagnostics, Inc. |
Influenza-Virus-Impfstoffe
|
JP4792390B2
(ja)
|
2004-03-29 |
2011-10-12 |
株式会社ガルファーマ |
新規ガレクチン9改変体タンパク質及びその用途
|
CA2822895A1
(en)
|
2004-05-25 |
2005-12-08 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
CA2610632C
(en)
|
2004-06-01 |
2022-10-04 |
Mount Sinai School Of Medicine Of New York University |
Genetically engineered swine influenza virus and uses thereof
|
US20080292658A1
(en)
*
|
2004-11-11 |
2008-11-27 |
Emmie De Wit |
Defective Influenza Virus Particles
|
MX2007005818A
(es)
|
2004-11-19 |
2007-07-20 |
Wisconsin Alumni Res Found |
Vectores recombinantes de la influenza con unidades de transcripcion en tandem.
|
US7959930B2
(en)
*
|
2004-12-24 |
2011-06-14 |
Abbott Biologicals B.V. |
Rescue of influenza virus
|
AU2011204881B2
(en)
*
|
2004-12-24 |
2012-04-19 |
Abbott Biologicals B.V. |
Rescue of influenza virus
|
EP1855713B1
(de)
*
|
2005-02-15 |
2016-04-27 |
Mount Sinai School of Medicine |
Gentechnisch hergestellter pferde-influenza-virus und seine verwendungen
|
ES2527503T3
(es)
|
2005-03-08 |
2015-01-26 |
Medimmune, Llc |
Virus influenza reordenantes
|
US20060216700A1
(en)
*
|
2005-03-10 |
2006-09-28 |
Medimmune Vaccines, Inc. |
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
|
EP1885402A4
(de)
*
|
2005-04-08 |
2010-11-10 |
Medimmune Inc |
Antikörper gegen metapneumovirus von säugetieren
|
EP1868650B1
(de)
|
2005-04-15 |
2018-10-03 |
MacroGenics, Inc. |
Kovalente diabodies und ihre verwendung
|
ES2526811T3
(es)
|
2005-08-10 |
2015-01-15 |
Macrogenics, Inc. |
Identificación y modificación de anticuerpos con regiones Fc variantes y métodos de uso de estos
|
WO2007061969A2
(en)
*
|
2005-11-18 |
2007-05-31 |
Rutgers, The State University |
Vaccines against influenza a and influenza b
|
AP2911A
(en)
|
2005-12-02 |
2014-05-31 |
Sinai School Medicine |
Chimeric Viruses presenting non-native surface proteins and uses thereof
|
AU2007245192B2
(en)
|
2006-03-31 |
2012-04-12 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
WO2007124327A2
(en)
|
2006-04-19 |
2007-11-01 |
Medimmune Llc. |
Methods and compositions for expressing negative-sense viral rna in canine cells
|
PT2054431E
(pt)
|
2006-06-09 |
2011-11-03 |
Novartis Ag |
Confórmeros de adesinas bacterianas
|
US7507411B2
(en)
*
|
2006-06-23 |
2009-03-24 |
University Of Saskatchewan |
Attenuated influenza NS1 variants
|
WO2008133701A1
(en)
*
|
2006-07-21 |
2008-11-06 |
Medimmune, Llc. |
Methods and compositions for increasing replication capacity of an influenza virus
|
CN104278014A
(zh)
*
|
2006-08-09 |
2015-01-14 |
米迪缪尼有限公司 |
流感血凝素和神经氨酸酶变体
|
CN101627113B
(zh)
|
2006-09-15 |
2013-04-24 |
米迪缪尼有限公司 |
支持病毒生长到高效价的mdck细胞系和采用该细胞系的生物反应器方法
|
WO2008100292A2
(en)
|
2006-10-16 |
2008-08-21 |
Genelux Corporation |
Modified vaccinia virus strains for use in diagnostic and therapeutic methods
|
US8597661B2
(en)
*
|
2007-05-04 |
2013-12-03 |
Wisconsin Alumni Research Foundation |
Neuraminidase-deficient live influenza vaccines
|
WO2008156778A2
(en)
|
2007-06-18 |
2008-12-24 |
Tokiko Watanabe |
Influenza m2 protein mutant viruses as live influenza attenuated vaccines
|
EP2674486A1
(de)
|
2007-06-18 |
2013-12-18 |
MedImmune, LLC |
Influenza-B-Viren mit Veränderungen im Hämagglutininpolypeptid
|
PL2158221T3
(pl)
|
2007-06-21 |
2019-02-28 |
Macrogenics, Inc. |
Kowalencyjne diaciała i ich zastosowania
|
US20090186050A1
(en)
*
|
2007-11-16 |
2009-07-23 |
Fouchier Ron A M |
Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
|
CA2730408A1
(en)
|
2008-07-11 |
2010-01-14 |
Chin-Fen Yang |
Influenza hemagglutinin and neuraminidase variants
|
KR20110074563A
(ko)
|
2008-09-24 |
2011-06-30 |
메디뮨 엘엘씨 |
바이러스의 정제 방법
|
AU2009335798B2
(en)
|
2008-12-19 |
2014-11-27 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
EP2987856B1
(de)
|
2009-02-05 |
2018-07-25 |
Icahn School of Medicine at Mount Sinai |
Chimäre newcastle-krankheitsviren und verwendungen davon
|
EP2396033B1
(de)
|
2009-02-12 |
2016-09-28 |
MedImmune, LLC |
Influenza-hämagglutinin- und neuraminidase-varianten
|
CA2787099A1
(en)
|
2009-03-30 |
2010-10-14 |
Anice C. Lowen |
Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
|
WO2011014504A1
(en)
|
2009-07-27 |
2011-02-03 |
Mount Sinai School Of Medicine Of New York University |
Recombinant influenza virus vectors and uses thereof
|
CA2805505C
(en)
|
2009-07-30 |
2021-08-03 |
Mount Sinai School Of Medecine |
Chimeric influenza viruses having reduced ability to reassort with other influenza viruses and uses thereof
|
SI2486141T1
(en)
|
2009-10-07 |
2018-06-29 |
Macrogenics, Inc. |
FC REGION-CONTAINING POLYPETHYDE, AFFECTING A BETTERED EFFECTORAL FUNCTION, BY CHANGES IN THE SCOPE OF FUKOZILATION AND METHODS FOR THEIR USE
|
WO2011056591A1
(en)
|
2009-10-26 |
2011-05-12 |
Warf - Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses with enhanced replication in vero cells
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
CA2792537A1
(en)
|
2010-03-30 |
2011-10-06 |
Mount Sinai School Of Medicine |
Influenza virus vaccines and uses thereof
|
US20130209406A1
(en)
*
|
2010-06-06 |
2013-08-15 |
Benjamin R. tenOever |
Recombinant rna viruses and uses thereof
|
MX339622B
(es)
|
2010-08-02 |
2016-06-02 |
Macrogenics Inc |
Diacuerpos covalentes y sus usos.
|
JP6145088B2
(ja)
|
2011-05-21 |
2017-06-07 |
マクロジェニクス,インコーポレーテッド |
脱免疫化血清結合ドメイン及び血清半減期を延長するためのその使用
|
US20130189303A1
(en)
|
2011-08-02 |
2013-07-25 |
Yan Zhou |
Recombinant swine influenza virus and uses thereof
|
EP2747778B1
(de)
|
2011-08-26 |
2017-12-06 |
Wisconsin Alumni Research Foundation |
Influenza-viren mit einem mutanten pb2-gensegment als lebende abgeschwächte impfstoffe
|
EP2758075B1
(de)
|
2011-09-20 |
2023-05-03 |
Icahn School of Medicine at Mount Sinai |
Influenzavirus-impfstoffe und verwendungen davon
|
WO2013130132A1
(en)
|
2011-10-07 |
2013-09-06 |
Medimmune, Llc |
Influenza hemagglutinin variants
|
NZ627796A
(en)
|
2012-12-18 |
2017-07-28 |
Icahn School Med Mount Sinai |
Influenza virus vaccines and uses thereof
|
WO2014159960A1
(en)
|
2013-03-14 |
2014-10-02 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
MX2015011886A
(es)
|
2013-03-14 |
2016-05-31 |
Icahn School Med Mount Sinai |
Virus de la enfermedad de newcastle y usos de los mismos.
|
EP3016660B1
(de)
|
2013-07-01 |
2020-06-10 |
The Research Foundation for the State University of New York |
Ship-hemmung gegen fettleibigkeit
|
EP3022296B1
(de)
|
2013-07-15 |
2022-12-28 |
Wisconsin Alumni Research Foundation |
Rekombinante influenzaviren mit hohem titer und erhöhter replikation in mdck- oder vero-zellen oder eiern
|
JP6857498B2
(ja)
|
2014-02-27 |
2021-04-14 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
癌を処置するための併用方法
|
CA2986354A1
(en)
|
2014-06-17 |
2015-12-30 |
The Research Foundation For The State University Of New York |
Ship inhibition to induce expression of granulocyte colony stimulating factor in a subject
|
WO2015196150A2
(en)
|
2014-06-20 |
2015-12-23 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
CN107208071B
(zh)
*
|
2014-11-13 |
2021-11-30 |
港大科桥有限公司 |
用于流感病毒的减弱活疫苗
|
JP2018504412A
(ja)
|
2015-01-23 |
2018-02-15 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
インフルエンザウイルスワクチン接種レジメン
|
EP3261664A1
(de)
|
2015-02-26 |
2018-01-03 |
Boehringer Ingelheim Vetmedica GmbH |
Bivalenter schweineinfluenzavirusimpfstoff
|
US10633422B2
(en)
|
2015-06-01 |
2020-04-28 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
|
US9890363B2
(en)
|
2015-07-06 |
2018-02-13 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication for vaccine development
|
WO2017031401A2
(en)
|
2015-08-20 |
2017-02-23 |
University Of Rochester |
Ns1 truncated virus for the development of canine influenza vaccines
|
WO2017031408A1
(en)
|
2015-08-20 |
2017-02-23 |
University Of Rochester |
Single-cycle virus for the development of canine influenza vaccines
|
MA42656A
(fr)
|
2015-08-20 |
2018-06-27 |
Univ Cornell |
Vaccin vivant atténué comprenant des mutations de polymérase virale pour le traitement et la prévention de virus de la grippe canine
|
WO2017040203A1
(en)
|
2015-08-28 |
2017-03-09 |
Yoshihiro Kawaoka |
Generation of infectious influenza viruses from virus-like particles
|
JP2019510481A
(ja)
|
2016-02-19 |
2019-04-18 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ワクチン開発のための改善されたb型インフルエンザウイルス複製
|
MX2018014955A
(es)
|
2016-06-03 |
2019-05-13 |
Univ Rochester |
Vacunas atenuadas vivas del virus de la influenza equina.
|
US11266734B2
(en)
|
2016-06-15 |
2022-03-08 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus hemagglutinin proteins and uses thereof
|
WO2018187706A2
(en)
|
2017-04-07 |
2018-10-11 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza b virus neuraminidase antibodies and uses thereof
|
JOP20190256A1
(ar)
|
2017-05-12 |
2019-10-28 |
Icahn School Med Mount Sinai |
فيروسات داء نيوكاسل واستخداماتها
|
EP3758748A1
(de)
|
2018-02-27 |
2021-01-06 |
University of Rochester |
Multivalenter abgeschwächter influenza-lebendimpfstoff zur vorbeugung und kontrolle des equinen influenzavirus (eiv) bei pferden
|
US11166996B2
(en)
|
2018-12-12 |
2021-11-09 |
Flagship Pioneering Innovations V, Inc. |
Anellovirus compositions and methods of use
|
US11241492B2
(en)
|
2019-01-23 |
2022-02-08 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to genes in influenza viruses
|
US11851648B2
(en)
|
2019-02-08 |
2023-12-26 |
Wisconsin Alumni Research Foundation (Warf) |
Humanized cell line
|
MX2021010343A
(es)
|
2019-02-27 |
2022-01-18 |
Univ Rochester |
Vacuna para la influenza multivalente con virus vivo atenuado para la prevencion y el control del virus de la influenza equina (eiv) en caballos.
|
US11390649B2
(en)
|
2019-05-01 |
2022-07-19 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication for vaccine development
|
EP4022046A2
(de)
|
2019-08-27 |
2022-07-06 |
Wisconsin Alumni Research Foundation (WARF) |
Rekombinante influenzaviren mit stabilisiertem ha zur replikation in eiern
|